Utilité des scores pour le suivi de la polyarthrite rhumatoïde et autres arthropathies inflammatoires [Use of clinical scores for rheumatoid arthritis and inflammatory rheumatic diseases in routine care]

Details

Ressource 1Download: RMS_773_462.pdf (389.78 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_E98C503ACF3D
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Utilité des scores pour le suivi de la polyarthrite rhumatoïde et autres arthropathies inflammatoires [Use of clinical scores for rheumatoid arthritis and inflammatory rheumatic diseases in routine care]
Journal
Revue medicale suisse
Author(s)
Schläpfer-Pessina A., Dumusc A.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
16/03/2022
Volume
18
Number
773
Pages
462-466
Language
french
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
Many clinical scores have been developed in research to measure rheumatoid arthritis (RA), spondyloarthritis (SpA) and psoriatic arthritis (PsA) activity. In routine care, they may be used as part of a treat to target (T2T) strategy consisting of a systematic evaluation of disease activity followed by an adaptation of the treatment in order to reach a predefined therapeutic target, generally remission. The benefits of this strategy have been showed in RA and its use is recommended for this condition. The added value of the T2T strategy for SpA and PsA remains debated, requiring further studies. Scores may be used for the follow-up of patients, but their limitations should be taken in consideration.
Keywords
Arthritis, Psoriatic/drug therapy, Arthritis, Psoriatic/therapy, Arthritis, Rheumatoid/drug therapy, Arthritis, Rheumatoid/therapy, Humans, Spondylarthritis/drug therapy, Spondylarthritis/therapy
Pubmed
Create date
06/04/2022 20:26
Last modification date
11/08/2023 6:17
Usage data